SEC Form 4 · accession 0001493152-15-004343
OncBioMune Pharmaceuticals, Inc · OBMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
American Capital Ventures, Inc.
10% Owner
Period of report
Aug 27, 2015
Accepted (ET)
Sep 15, 2015 · 6:04 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362703
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 27, 2015 | J | 666,666 | $0.003 | A | 1,648,831 | D | |
| Common StockF1 | holding | — | — | — | 982,165 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Share amount gives effect to the issuer's reverse stock split effected on August 27, 2015.
- F2On August 27, 2015, the reporting person acquired these shares through settlement of $2,000.00 of debt of the issuer held by the reporting Person.